Frontier Biotechnologies (SHSE:688221) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688221 Frontier Biotechnologies Inc SHSE:688221
73 GF Score
Price ¥21.32
GF Value ¥37.37
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Frontier Biotechnologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Frontier Biotechnologies Valuation Rank Related Terms

SHSE:688221
73GF Score
Frontier Biotechnologies Inc SHSE:688221
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Frontier Biotechnologies (SHSE:688221) Overvalued in 2026?

Based on GuruFocus' analysis, Frontier Biotechnologies stock appears to be undervalued. The current stock price of ¥21.32 is trading 42.9% below its estimated GF Value™ of ¥37.37. GuruFocus considers Frontier Biotechnologies to be Significantly Undervalued.

Key valuation signals for SHSE:688221:

  • Valuation Rank:
  • GF Value™: ¥37.37 vs. price of ¥21.32 (42.9% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688221 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Frontier Biotechnologies Business Description

Address Dongshan Street, 11th Floor, Building E-2, Greenland Window, Jiangning District, Jiangsu Province, Nanjing, CHN, 211199
Frontier Biotechnologies Inc is engaged in the Research, development, production, and marketing of inventive drugs that address unmet clinical needs.
73GF Score

Get the complete analysis for SHSE:688221

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.32
Price
¥37.37
GF Value